Home » Companies

Image for EastGroup Properties, Inc. (NYSE:EGP) Plans Quarterly Dividend of $1.10

EastGroup Properties, Inc. (NYSE:EGP) Plans Quarterly Dividend of $1.10

EastGroup Properties, Inc. (NYSE:EGP – Get Rating) declared a quarterly dividend on Friday, May 27th, Wall Street Journal reports. Stockholders of record on Thursday, June 30th will be paid a dividend of 1.10 per share by the... More of this article »
Image for Virtus Stone Harbor Emerging Markets Total Income Fund Announces Monthly Dividend of $0.07 (NYSE:EDI)

Virtus Stone Harbor Emerging Markets Total Income Fund Announces Monthly Dividend of $0.07 (NYSE:EDI)

Virtus Stone Harbor Emerging Markets Total Income Fund (NYSE:EDI – Get Rating) announced a monthly dividend on Friday, May 27th, Wall Street Journal reports. Shareholders of record on Tuesday, July 12th will be given a dividend... More of this article »
Image for ASGN (NYSE:ASGN) Lowered to Hold at Zacks Investment Research

ASGN (NYSE:ASGN) Lowered to Hold at Zacks Investment Research

ASGN (NYSE:ASGN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “ASGN... More of this article »
Image for Avid Technology (NASDAQ:AVID) Upgraded to Buy by Zacks Investment Research

Avid Technology (NASDAQ:AVID) Upgraded to Buy by Zacks Investment Research

Avid Technology (NASDAQ:AVID – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Friday, Zacks.com reports. The brokerage currently... More of this article »
Image for Zacks Investment Research Upgrades ASE Technology (NYSE:ASX) to “Hold”

Zacks Investment Research Upgrades ASE Technology (NYSE:ASX) to “Hold”

ASE Technology (NYSE:ASX – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports. According to Zacks,... More of this article »
Image for Biofrontera (NASDAQ:BFRI) Downgraded by Zacks Investment Research

Biofrontera (NASDAQ:BFRI) Downgraded by Zacks Investment Research

Biofrontera (NASDAQ:BFRI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Biofrontera... More of this article »
Image for Aura Biosciences (NASDAQ:AURA) Rating Lowered to Hold at Zacks Investment Research

Aura Biosciences (NASDAQ:AURA) Rating Lowered to Hold at Zacks Investment Research

Aura Biosciences (NASDAQ:AURA – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Friday, Zacks.com reports. According to Zacks,... More of this article »
Image for Altus Power (NYSE:AMPS) Stock Rating Lowered by Zacks Investment Research

Altus Power (NYSE:AMPS) Stock Rating Lowered by Zacks Investment Research

Altus Power (NYSE:AMPS – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “Altus... More of this article »
Image for Movado Group (NYSE:MOV) Issues Quarterly  Earnings Results

Movado Group (NYSE:MOV) Issues Quarterly Earnings Results

Movado Group (NYSE:MOV – Get Rating) issued its quarterly earnings data on Thursday. The company reported $0.82 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.36, MarketWatch Earnings reports.... More of this article »
Image for Investment Analysts’ Updated EPS Estimates for May 27th (AAWH, ABEO, ACH, ACHR, ADMP, ADSE, AFLYY, AMAM, AMPS, CGC)

Investment Analysts’ Updated EPS Estimates for May 27th (AAWH, ABEO, ACH, ACHR, ADMP, ADSE, AFLYY, AMAM, AMPS, CGC)

Investment Analysts’ updated eps estimates for Friday, May 27th: Ascend Wellness (OTC:AAWH) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Ascend Wellness... More of this article »
Image for Stock Analysts’ Price Target Changes for May 27th (ACHL, ADEVF, ANPCY, ATDRY, ATGSY, AVDL, BKKVF, BMEA, BNDSF, BNTGY)

Stock Analysts’ Price Target Changes for May 27th (ACHL, ADEVF, ANPCY, ATDRY, ATGSY, AVDL, BKKVF, BMEA, BNDSF, BNTGY)

Stock Analysts’ price target changes for Friday, May 27th: Achilles Therapeutics (NASDAQ:ACHL) had its target price trimmed by Piper Sandler from $17.00 to $10.00. Adevinta ASA (OTCMKTS:ADEVF) had its price target reduced by... More of this article »
Image for First Trust Dorsey Wright International Focus 5 ETF (NASDAQ:IFV) Short Interest Up 101.7% in May

First Trust Dorsey Wright International Focus 5 ETF (NASDAQ:IFV) Short Interest Up 101.7% in May

First Trust Dorsey Wright International Focus 5 ETF (NASDAQ:IFV – Get Rating) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 12,100 shares,... More of this article »
Image for iPower Inc. (NASDAQ:IPW) Short Interest Down 60.9% in May

iPower Inc. (NASDAQ:IPW) Short Interest Down 60.9% in May

iPower Inc. (NASDAQ:IPW – Get Rating) saw a large decrease in short interest in May. As of May 15th, there was short interest totalling 181,200 shares, a decrease of 60.9% from the April 30th total of 462,900 shares. Currently,... More of this article »
Image for ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS) Short Interest Update

ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS) Short Interest Update

ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS – Get Rating) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 35,900 shares, a growth of 100.6% from the April... More of this article »
Image for Hudson Technologies, Inc. (NASDAQ:HDSN) Sees Significant Growth in Short Interest

Hudson Technologies, Inc. (NASDAQ:HDSN) Sees Significant Growth in Short Interest

Hudson Technologies, Inc. (NASDAQ:HDSN – Get Rating) was the target of a large increase in short interest in May. As of May 15th, there was short interest totalling 1,330,000 shares, an increase of 105.3% from the April 30th... More of this article »
Image for Maxar Technologies (MAXR) – Investment Analysts’ Recent Ratings Changes

Maxar Technologies (MAXR) – Investment Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for Maxar Technologies (NYSE: MAXR): 5/26/2022 – Maxar Technologies had its price target raised by analysts at TD Securities from $43.00 to $45.00. They... More of this article »
Image for Sumo Logic (NASDAQ:SUMO) Releases Quarterly  Earnings Results, Beats Estimates By $0.04 EPS

Sumo Logic (NASDAQ:SUMO) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Sumo Logic (NASDAQ:SUMO – Get Rating) issued its quarterly earnings data on Thursday. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.17) by $0.04, Briefing.com reports.... More of this article »
Image for Piper Sandler Cuts ImmunityBio (NASDAQ:IBRX) Price Target to $10.00

Piper Sandler Cuts ImmunityBio (NASDAQ:IBRX) Price Target to $10.00

ImmunityBio (NASDAQ:IBRX – Get Rating) had its target price reduced by equities researchers at Piper Sandler from $20.00 to $10.00 in a report released on Friday, The Fly reports. Piper Sandler’s price target points to... More of this article »
Image for Piper Sandler Trims Neoleukin Therapeutics (NASDAQ:NLTX) Target Price to $6.00

Piper Sandler Trims Neoleukin Therapeutics (NASDAQ:NLTX) Target Price to $6.00

Neoleukin Therapeutics (NASDAQ:NLTX – Get Rating) had its target price cut by Piper Sandler from $25.00 to $6.00 in a note issued to investors on Friday, The Fly reports. Separately, Zacks Investment Research downgraded shares... More of this article »
Image for Piper Sandler Cuts Leap Therapeutics (NASDAQ:LPTX) Price Target to $4.00

Piper Sandler Cuts Leap Therapeutics (NASDAQ:LPTX) Price Target to $4.00

Leap Therapeutics (NASDAQ:LPTX – Get Rating) had its target price reduced by equities researchers at Piper Sandler from $6.00 to $4.00 in a research note issued to investors on Friday, The Fly reports. Piper Sandler’s... More of this article »
Image for Marker Therapeutics (NASDAQ:MRKR) Price Target Lowered to $1.50 at Piper Sandler

Marker Therapeutics (NASDAQ:MRKR) Price Target Lowered to $1.50 at Piper Sandler

Marker Therapeutics (NASDAQ:MRKR – Get Rating) had its price objective cut by investment analysts at Piper Sandler from $3.50 to $1.50 in a research report issued to clients and investors on Friday, The Fly reports. Piper Sandler’s... More of this article »
Image for Gracell Biotechnologies (NASDAQ:GRCL) Price Target Cut to $10.00 by Analysts at Piper Sandler

Gracell Biotechnologies (NASDAQ:GRCL) Price Target Cut to $10.00 by Analysts at Piper Sandler

Gracell Biotechnologies (NASDAQ:GRCL – Get Rating) had its target price reduced by equities research analysts at Piper Sandler from $25.00 to $10.00 in a report released on Friday, The Fly reports. Piper Sandler’s price... More of this article »
Image for Cardiff Oncology (NASDAQ:CRDF) PT Lowered to $7.00

Cardiff Oncology (NASDAQ:CRDF) PT Lowered to $7.00

Cardiff Oncology (NASDAQ:CRDF – Get Rating) had its target price lowered by Piper Sandler from $20.00 to $7.00 in a research note issued on Friday, The Fly reports. Piper Sandler’s target price would indicate a potential... More of this article »
Image for Piper Sandler Cuts Achilles Therapeutics (NASDAQ:ACHL) Price Target to $10.00

Piper Sandler Cuts Achilles Therapeutics (NASDAQ:ACHL) Price Target to $10.00

Achilles Therapeutics (NASDAQ:ACHL – Get Rating) had its price target cut by analysts at Piper Sandler from $17.00 to $10.00 in a research report issued to clients and investors on Friday, The Fly reports. Piper Sandler’s... More of this article »
Image for Ocular Therapeutix (NASDAQ:OCUL) PT Lowered to $10.00

Ocular Therapeutix (NASDAQ:OCUL) PT Lowered to $10.00

Ocular Therapeutix (NASDAQ:OCUL – Get Rating) had its price objective cut by equities researchers at Piper Sandler from $16.00 to $10.00 in a research report issued to clients and investors on Friday, The Fly reports. Piper... More of this article »
Image for I-Mab (NASDAQ:IMAB) PT Lowered to $35.00 at Piper Sandler

I-Mab (NASDAQ:IMAB) PT Lowered to $35.00 at Piper Sandler

I-Mab (NASDAQ:IMAB – Get Rating) had its price target decreased by Piper Sandler from $80.00 to $35.00 in a report released on Friday, The Fly reports. Piper Sandler’s price target points to a potential upside of 323.22%... More of this article »
Image for CytomX Therapeutics (NASDAQ:CTMX) PT Lowered to $10.00 at Piper Sandler

CytomX Therapeutics (NASDAQ:CTMX) PT Lowered to $10.00 at Piper Sandler

CytomX Therapeutics (NASDAQ:CTMX – Get Rating) had its price target dropped by investment analysts at Piper Sandler from $16.00 to $10.00 in a research note issued to investors on Friday, The Fly reports. A number of other analysts... More of this article »
Image for Piper Sandler Lowers Oyster Point Pharma (NASDAQ:OYST) Price Target to $15.00

Piper Sandler Lowers Oyster Point Pharma (NASDAQ:OYST) Price Target to $15.00

Oyster Point Pharma (NASDAQ:OYST – Get Rating) had its target price dropped by equities research analysts at Piper Sandler from $60.00 to $15.00 in a research note issued to investors on Friday, The Fly reports. Piper Sandler’s... More of this article »
Image for Craig Hallum Cuts Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target to $15.50

Craig Hallum Cuts Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target to $15.50

Avadel Pharmaceuticals (NASDAQ:AVDL – Get Rating) had its price target lowered by analysts at Craig Hallum from $20.00 to $15.50 in a research note issued to investors on Friday, The Fly reports. Several other research firms... More of this article »
Image for Harpoon Therapeutics (NASDAQ:HARP) PT Lowered to $9.00

Harpoon Therapeutics (NASDAQ:HARP) PT Lowered to $9.00

Harpoon Therapeutics (NASDAQ:HARP – Get Rating) had its price objective lowered by research analysts at Piper Sandler from $14.00 to $9.00 in a research report issued on Friday, The Fly reports. Piper Sandler’s price objective... More of this article »
Image for Piper Sandler Trims Rain Therapeutics (NASDAQ:RAIN) Target Price to $12.00

Piper Sandler Trims Rain Therapeutics (NASDAQ:RAIN) Target Price to $12.00

Rain Therapeutics (NASDAQ:RAIN – Get Rating) had its price objective dropped by analysts at Piper Sandler from $26.00 to $12.00 in a research report issued to clients and investors on Friday, The Fly reports. Piper Sandler’s... More of this article »
Image for Biomea Fusion (NASDAQ:BMEA) PT Lowered to $16.00

Biomea Fusion (NASDAQ:BMEA) PT Lowered to $16.00

Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price reduced by investment analysts at Piper Sandler from $25.00 to $16.00 in a report released on Friday, The Fly reports. Piper Sandler’s price target points to... More of this article »
Image for Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Short Interest Down 59.9% in May

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Short Interest Down 59.9% in May

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Get Rating) saw a significant decline in short interest in May. As of May 15th, there was short interest totalling 54,500 shares, a decline of 59.9% from the April 30th total... More of this article »
Image for Mountain Crest Acquisition Corp. III (NASDAQ:MCAE) Sees Large Drop in Short Interest

Mountain Crest Acquisition Corp. III (NASDAQ:MCAE) Sees Large Drop in Short Interest

Mountain Crest Acquisition Corp. III (NASDAQ:MCAE – Get Rating) was the recipient of a large decrease in short interest in May. As of May 15th, there was short interest totalling 900 shares, a decrease of 59.1% from the April... More of this article »
Image for MINISO Group (NYSE:MNSO) Issues Quarterly  Earnings Results

MINISO Group (NYSE:MNSO) Issues Quarterly Earnings Results

MINISO Group (NYSE:MNSO – Get Rating) released its earnings results on Thursday. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.49 by ($0.13), Fidelity Earnings reports. MINISO... More of this article »
Image for Manchester United (NYSE:MANU) Releases  Earnings Results, Misses Estimates By $13.63 EPS

Manchester United (NYSE:MANU) Releases Earnings Results, Misses Estimates By $13.63 EPS

Manchester United (NYSE:MANU – Get Rating) released its quarterly earnings data on Thursday. The company reported ($13.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($13.63),... More of this article »
Image for Movado Group (NYSE:MOV) Releases  Earnings Results, Beats Estimates By $0.36 EPS

Movado Group (NYSE:MOV) Releases Earnings Results, Beats Estimates By $0.36 EPS

Movado Group (NYSE:MOV – Get Rating) issued its earnings results on Thursday. The company reported $0.82 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.36, MarketWatch Earnings reports. Movado... More of this article »
Image for StepStone Group (NASDAQ:STEP) Announces Quarterly  Earnings Results

StepStone Group (NASDAQ:STEP) Announces Quarterly Earnings Results

StepStone Group (NASDAQ:STEP – Get Rating) released its earnings results on Thursday. The company reported $0.38 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.02), Briefing.com reports. The firm had revenue... More of this article »
Image for Weekly Investment Analysts’ Ratings Updates for CME Group (CME)

Weekly Investment Analysts’ Ratings Updates for CME Group (CME)

CME Group (NASDAQ: CME) has recently received a number of price target changes and ratings updates: 5/25/2022 – CME Group was upgraded by analysts at Oppenheimer Holdings Inc. from a “market perform” rating to an... More of this article »
Image for JD.com (JD) – Investment Analysts’ Recent Ratings Updates

JD.com (JD) – Investment Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for JD.com (NASDAQ: JD): 5/26/2022 – JD.com was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating. 5/24/2022... More of this article »
Image for Rio Tinto Group (RIO) – Research Analysts’ Weekly Ratings Changes

Rio Tinto Group (RIO) – Research Analysts’ Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Rio Tinto Group (LON: RIO) in the last few weeks: 5/23/2022 – Rio Tinto Group had its “hold” rating reaffirmed by analysts at... More of this article »
Image for Bloomin’ Brands (NASDAQ:BLMN) vs. Portillo’s (NASDAQ:PTLO) Head-To-Head Survey

Bloomin’ Brands (NASDAQ:BLMN) vs. Portillo’s (NASDAQ:PTLO) Head-To-Head Survey

Portillo’s (NASDAQ:PTLO – Get Rating) and Bloomin’ Brands (NASDAQ:BLMN – Get Rating) are both small-cap retail/wholesale companies, but which is the better stock? We will compare the two companies based on the... More of this article »
Image for Samsara (NYSE:IOT) & Digimarc (NASDAQ:DMRC) Head to Head Contrast

Samsara (NYSE:IOT) & Digimarc (NASDAQ:DMRC) Head to Head Contrast

Digimarc (NASDAQ:DMRC – Get Rating) and Samsara (NYSE:IOT – Get Rating) are both industrial products companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings,... More of this article »
Image for Contrasting Avista (NYSE:AVA) & Via Renewables (NASDAQ:VIA)

Contrasting Avista (NYSE:AVA) & Via Renewables (NASDAQ:VIA)

Avista (NYSE:AVA – Get Rating) and Via Renewables (NASDAQ:VIA – Get Rating) are both utilities companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations,... More of this article »
Image for Potbelly (NASDAQ:PBPB) vs. FAT Brands (NASDAQ:FATBB) Critical Comparison

Potbelly (NASDAQ:PBPB) vs. FAT Brands (NASDAQ:FATBB) Critical Comparison

Potbelly (NASDAQ:PBPB – Get Rating) and FAT Brands (NASDAQ:FATBB – Get Rating) are both small-cap retail/wholesale companies, but which is the better business? We will compare the two companies based on the strength of... More of this article »
Image for Comparing Sunshine Biopharma (NASDAQ:SBFM) and Incyte (NASDAQ:INCY)

Comparing Sunshine Biopharma (NASDAQ:SBFM) and Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY – Get Rating) and Sunshine Biopharma (NASDAQ:SBFM – Get Rating) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional... More of this article »
Image for Reviewing Crown (NYSE:CCK) and Ball (NYSE:BALL)

Reviewing Crown (NYSE:CCK) and Ball (NYSE:BALL)

Crown (NYSE:CCK – Get Rating) and Ball (NYSE:BALL – Get Rating) are both large-cap industrial products companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional... More of this article »
Image for Contrasting Convey Health Solutions (CNVY) & Its Rivals

Contrasting Convey Health Solutions (CNVY) & Its Rivals

Convey Health Solutions (NYSE:CNVY – Get Rating) is one of 29 publicly-traded companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it compare to its competitors?... More of this article »
Image for Reviewing Quantum-Si (QSI) and Its Competitors

Reviewing Quantum-Si (QSI) and Its Competitors

Quantum-Si (NASDAQ:QSI – Get Rating) is one of 28 public companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it weigh in compared to its rivals? We will compare... More of this article »
Image for Critical Analysis: Singular Genomics Systems (OMIC) & Its Peers

Critical Analysis: Singular Genomics Systems (OMIC) & Its Peers

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it contrast to its peers? We will compare Singular Genomics Systems to related... More of this article »